Publications

2012
81. The use of non-viral gene vectors for bioactive poly-(D,L-lactide) implant surfaces in bone tissue engineering.
Reckhenrich AK, Koch C, Egaña JT, Plank C
Eur Cell Mater. 2012 .
PMID: 22736203
82. S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F
Immunology. 2012 Jun .
PMID: 22304731 [PubMed - in process]
83. Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.
Schäfer H, Dieckmann C, Korniienko O, Moldenhauer G, Kiefel H, Salnikov A, Krüger A, Altevogt P, Sebens S
Cancer Lett. 2012 Jun 1.
PMID: 22210381 [PubMed - in process]
84. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.
Gotot J, Gottschalk C, Leopold S, Knolle PA, Yagita H, Kurts C, Ludwig-Portugall I
Proc Natl Acad Sci U S A. 2012 Jun 26.
PMID: 22689978 [PubMed - in process]
85. Optimizing adenoviral transduction of endothelial cells under flow conditions.
Anton M, Wolf A, Mykhaylyk O, Koch C, Gansbacher B, Plank C
Pharm Res. 2012 May .
PMID: 22207207 [PubMed - in process]
86. Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection.
Abdullah Z, Geiger S, Nino-Castro A, Böttcher JP, Muraliv E, Gaidt M, Schildberg FA, Riethausen K, Flossdorf J, Krebs W, Chakraborty T, Kurts C, Schultze JL, Knolle PA, Klotz L
PLoS One. 2012 .
PMID: 22629382 [PubMed - in process]
87. Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.
Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigtländer T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, Korangy F, Greten TF
J Immunol. 2012 Jun 15.
PMID: 22615204 [PubMed - in process]
88. Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.
Trueck C, Zimmermann K, Mykhaylyk O, Anton M, Vosen S, Wenzel D, Fleischmann BK, Pfeifer A
Pharm Res. 2012 May .
PMID: 22274554 [PubMed - in process]
89. Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.
Mykhaylyk O, Sobisch T, Almstätter I, Sanchez-Antequera Y, Brandt S, Anton M, Döblinger M, Eberbeck D, Settles M, Braren R, Lerche D, Plank C
Pharm Res. 2012 May .
PMID: 22222384 [PubMed - in process]
90. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L
Brain. 2012 May .
PMID: 22447120 [PubMed - in process]